White label ELPA - ClinicalTrials.eu

Study on the Use of Casirivimab, Cilgavimab, Sotrovimab, and Nirmatrelvir for Patients with COVID-19 Infection

Not recruiting

3 1 1 1
Investigated Diseases:
- COVID-19
Investigated Drugs:
Study on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute coronary syndrome
Investigated Drugs:
- Ticagrelor
Study on Blood Vessel Changes in Basal Cell Carcinoma Patients Treated with Bleomycin or Drug Combination

Not recruiting

2 1 1 1
Investigated Diseases:
- Basal cell carcinoma
Investigated Drugs:
- Bleomycin
Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Avelumab
Study on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Acute coronary syndrome
Investigated Drugs:
- Acetylsalicylic Acid
- Ticagrelor
Study on Rituximab and Cyclophosphamide for Treating ANCA-Associated Vasculitis in Patients Seeking Remission

Not recruiting

2 1 1 1 1
Investigated Diseases:
- Anti-neutrophil cytoplasmic antibody positive vasculitis
Investigated Drugs:
- Cyclophosphamide
- Rituximab
Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Psychotic behaviour
- Psychotic disorder
Investigated Drugs:
Study on the Safety and Effects of BIIB122 for Patients with LRRK2-Associated Parkinson’s Disease

Not recruiting

2 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
Study on the Use of Flutemetamol (18F) for Diagnosing Cardiac Amyloidosis in Patients

Not recruiting

2 1 1 1
Investigated Drugs:
- Flutemetamol (18F)
Study on Doxorubicin Hydrochloride and Trabectedin for Patients with Recurrent Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
- Doxorubicin Hydrochloride
- Trabectedin

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies